These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26616555)

  • 1. Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties.
    Zhao N; Dong Q; Qian C; Li S; Wu QF; Ding D; Li J; Wang BB; Guo KF; Xie JJ; Cheng X; Liao YH; Du YM
    Sci Rep; 2015 Nov; 5():17381. PubMed ID: 26616555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acacetin blocks kv1.3 channels and inhibits human T cell activation.
    Zhao N; Dong Q; Fu XX; Du LL; Cheng X; Du YM; Liao YH
    Cell Physiol Biochem; 2014; 34(4):1359-72. PubMed ID: 25301362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells.
    Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM
    J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells.
    Zhao N; Dong Q; Du LL; Fu XX; Du YM; Liao YH
    PLoS One; 2013; 8(5):e64629. PubMed ID: 23717641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toxin mimic FS48 from the salivary gland of Xenopsylla cheopis functions as a Kv1.3 channel-blocking immunomodulator of T cell activation.
    Zeng Q; Lu W; Deng Z; Zhang B; Wu J; Chai J; Chen X; Xu X
    J Biol Chem; 2022 Jan; 298(1):101497. PubMed ID: 34919963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers.
    Fung-Leung WP; Edwards W; Liu Y; Ngo K; Angsana J; Castro G; Wu N; Liu X; Swanson RV; Wickenden AD
    PLoS One; 2017; 12(1):e0170102. PubMed ID: 28107393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes.
    Ren YR; Pan F; Parvez S; Fleig A; Chong CR; Xu J; Dang Y; Zhang J; Jiang H; Penner R; Liu JO
    PLoS One; 2008; 3(12):e4009. PubMed ID: 19104661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
    Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
    Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-dioxin-like polychlorinated biphenyl 19 has distinct effects on human Kv1.3 and Kv1.5 channels.
    Kim JH; Hwang S; Jo SH
    Toxicol Appl Pharmacol; 2021 Jan; 411():115365. PubMed ID: 33316272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
    Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
    Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
    Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
    Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
    Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
    J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein inhibits the activity of kv1.3 potassium channels in human T lymphocytes.
    Teisseyre A; Michalak K
    J Membr Biol; 2005 May; 205(2):71-9. PubMed ID: 16283587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
    Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
    Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide blockers of K
    Chandy KG; Norton RS
    Curr Opin Chem Biol; 2017 Jun; 38():97-107. PubMed ID: 28412597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.
    Beeton C; Pennington MW; Wulff H; Singh S; Nugent D; Crossley G; Khaytin I; Calabresi PA; Chen CY; Gutman GA; Chandy KG
    Mol Pharmacol; 2005 Apr; 67(4):1369-81. PubMed ID: 15665253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Inflammatory Effect of Licochalcone A via Regulation of ORAI1 and K
    Phan HTL; Kim HJ; Jo S; Kim WK; Namkung W; Nam JH
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium channels as therapeutic targets for autoimmune disorders.
    Wulff H; Beeton C; Chandy KG
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cells.
    Yang JF; Cheng N; Ren S; Liu XM; Li XT
    Eur J Pharmacol; 2018 Sep; 834():206-212. PubMed ID: 30016664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of copper ions on lymphocyte Kv1.3 potassium channels.
    Teisseyre A; Mozrzymas JW
    J Physiol Pharmacol; 2006 Jun; 57(2):301-14. PubMed ID: 16845233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.